Aspen Alert’s Post

𝗡𝗘𝗪 𝗣𝗥𝗢𝗝𝗘𝗖𝗧 | Recycling pathways for single-use flexible plastic bags in pharmaceutical applications We're excited to share progress from our consortium, which comprises key partners such as Janssen-Biologics, Wittenburg BV, RENOLIT Healthcare Solutions, Avantor Sciences, Thermo Fisher, Polymer Science Park, Bristol Myers Squibb, BioBTX and Netherlands Foreign Investment Agency (NFIA) on developing recycling pathways for single-use flexible plastic bags in pharmaceutical settings. Our collaborative effort is focused on sustainable end-of-life solutions for these materials, which are rich in recyclable polyethylene (PE). Phase 1 insights have revealed that both mechanical and chemical recycling methods hold promise after the removal of single-use assemblies from the bioreactor bags. Mechanical recycling has been identified as a low CO2 impact route for creating new packaging, while chemical recycling could provide new building blocks for circular production. The next phase aims to expand our business case, requiring more end users to join the initiative and a waste handler partner for decontamination services. This expansion is crucial for the economic viability of the recycling process and compliance with regulatory standards. ➡️ For more information or to join us, we invite you to reach out and connect with us #sustainability #pharma #recyclinginnovation #circulareconomy #circularplastics J&J Innovative Medicine Nederland TNO

I think the bioplastics industry is fascinating. The market size is estimated at $8B and expected to grow to $19B by 2030. Personally, I think it will be even bigger, especially if governments get behind the industry in a more meaningful way. For those new to the term, here’s a good overview article to get you up to speed. #bioplastics

Lummus Technology, a global leader in process technologies, and RWDC Industries, a biotechnology firm pioneering biopolymer solutions, have inked a binding Joint Development and Commercial Cooperation Agreement (JDCCA) to accelerate the production and worldwide licensing of polyhydroxyalkanoates (PHA). This partnership, stemming from their April memorandum of understanding (MOU), marks a significant stride towards sustainable materials. Learn how Lummus and RWDC are reshaping the future of biopolymers: https://lnkd.in/dWduA2KA #biopolymers #memorandumofunderstanding #sustainablematerials #sustainability #biotechnologyindustry #chemicalmanagement #chemicalindustry #chemicalreport #media7

AIMPLAS · Technological Institute of Plastics has apparently converted synthetic plastics into biodegradable bioplastics through methods based on microwaves and reactive extrusion as part of the BioICEP TCD Project; the results are set for use in the packaging and pharma industries To get access to unmissable exclusive content and enhanced personalisation options, become a Packaging Europe subscriber (for free): https://lnkd.in/e3xexKss Follow our hashtag to stay up to date with the latest packaging news: #PackagingEurope

𝐏𝐨𝐥𝐲𝐛𝐮𝐭𝐲𝐥𝐞𝐧𝐞 𝐒𝐮𝐜𝐜𝐢𝐧𝐚𝐭𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 is forecast to reach $155.7 million by 2030, after growing at a CAGR of 9% during 2024-2030. as per IndustryARC Latest Market Research Report.   Check Market Research 𝑹𝒆𝒑𝒐𝒓𝒕 Here @ https://lnkd.in/gdus3msk   𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 𝐑𝐢𝐬𝐢𝐧𝐠 𝐃𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐁𝐢𝐨𝐝𝐞𝐠𝐫𝐚𝐝𝐚𝐛𝐥𝐞 𝐏𝐥𝐚𝐬𝐭𝐢𝐜𝐬: There is a growing preference for biodegradable materials due to increasing environmental concerns and governmental regulations aimed at reducing plastic waste. This trend is particularly strong in the packaging industry, where companies are shifting towards sustainable packaging solutions to meet consumer demand and regulatory requirements. 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐚𝐧𝐝 𝐑&𝐃: Continuous advancements in PBS production and applications are propelling market growth. Companies are investing heavily in research and development to create innovative PBS-based products, particularly in packaging, agriculture (e.g., mulch films), and medical applications such as tissue engineering. 𝐓𝐨 𝐁𝐮𝐲 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 / 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞 @ https://lnkd.in/gmTWphFT   𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐈𝐧𝐢𝐭𝐢𝐚𝐭𝐢𝐯𝐞𝐬 𝐛𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: Major players in the PBS market are focusing on partnerships, mergers, and acquisitions to expand their market presence and enhance their product offerings. For example, joint ventures like PTT MCC Biochem (a collaboration between Mitsubishi Chemical and PTT Global Chemical) are crucial in driving the development and production of bio-based PBS. 𝐤𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬  : DuPont, NatureWorks, BASF, Corbion, Mitsubishi Chemical Group, Eastman, Toray Industries, Inc., Novamont, Braskem, BASF, Corbion, Mitsubishi Chemical Group, Novamont, TotalEnergies, Arkema, LyondellBasell, Evonik, LANXESS, Solvay #PolybutyleneSuccinate #BiodegradablePlastic #EcoFriendlyMaterial #SustainablePackaging #GreenTechnology #Biopolymer #PlasticAlternatives #BioBasedPlastic #RenewableResource #CircularEconomy

Experts and stakeholders in Europe's bioplastics sector discussed its challenges and opportunities in a session at the EBC 23- EBC 23, the European Bioplastics Conference in Berlin in December. What did they say? Find out in our latest blog post. 🔎 https://lnkd.in/gFQiEACT #bioplastics #chemicals #sustainablefuture

Our publication on "Efficient Bioproduction of Poly(3-hydroxypropionate) Homopolymer using Engineered Escherichia coli Strains" has been accepted and published in Bioresource Technology Journal. This study outlined a multi-faceted strategy for optimizing the downstream biosynthetic pathway of Poly(3-hydroxypropionate), a biodegradable polymer with unique physico-mechanical properties that makes it a potential substitute for conventional plastics. Our findings underscore the feasibility of producing this eco-friendly polymer in scalable metrics, contributing to efforts aimed at addressing the pressing issue of plastic pollution. You can access the full paper here: https://lnkd.in/dmv4PGrs

Did you know that pharma’s CO2 footprint is expected to triple by 2050 if left unchecked? These are more than just statistics; they're a call to action. Fortunately, there seems to be a solution: Green Chemistry. Here's why it matters: 👉𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆: Green Chemistry promotes safer, #sustainable chemicals and processes, reducing our environmental footprint. 👉𝗜𝗺𝗽𝗮𝗰𝘁 𝗼𝗻 𝗣𝗵𝗮𝗿𝗺𝗮: The #pharmaceutical industry is a significant contributor to global #carbon emissions and waste. Green Chemistry can help reduce these impacts by improving process efficiency and reducing waste. 👉𝗖𝗮𝘀𝗲 𝗦𝘁𝘂𝗱𝘆: DUDE CHEM, a green chemistry startup, is disrupting the pharmaceutical industry. Using high-tech computer modelling techniques and a patented green tech toolbox, they've developed new chemical processes that reduce waste and improve efficiency. One process under development has reported a 71% reduction in waste. Incredible, isn’t it? 👉𝗧𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲: Dude Chem's approach shows that Green Chemistry isn't just good for the planet; it's also good for business. How? By reducing waste, they're not only reducing their environmental impact but also saving costs. For more insights, check out this report: https://lnkd.in/gifFgiqt Together, let's not just shape the future—let's ensure it's a future we can all thrive in. 💚 #greenchemistry #futureofhealthcare #pharmaceuticalindustry #carbonfootprint #sustainablefuture

Great article here highlighting some of the environmental impacts and sustainable strategies in the pharmaceutical industry. “Sustainability in the pharmaceutical industry refers to the industry's ability to meet the needs of the present without compromising the ability of future generations to meet their own needs. The industry must find ways to reduce its impact on the environment, conserve natural resources, and promote sustainable development.” Some of the practices discussed like waste reduction, water conservation, and “greening the supply chain” are things Polycarbin directly addresses. Happy to connect with any Scientists, EH&S, Procurement, or leaders in the space to discuss how we can immediately decrease the 4.4% of worldwide emissions our industry is accountable for. #circulareconomy #sustainability #decarbonizethesupplychain

"JC: Compact instruments in pharma and biopharma labs bring forth numerous sustainability advantages. They possess smaller manufacturing and transportation footprints, reducing the environmental effects of production and distribution. Moreover, these instruments often consume less energy, thereby decreasing operational expenses, chemical usage and – potentially – carbon emissions. Their compact design also fosters well-organized lab layouts, optimizing resource utilization and reducing the necessity for extra infrastructure." ... JC: The industry's reliance on single-use plastics and resource-intensive processes is deeply ingrained, requiring substantial changes to establish more sustainable operations. A significant barrier to implementing environmental changes within the pharma manufacturing industry today is measuring and reducing indirect emissions in a company's value chain, such as from suppliers or customers." #sustainability #sustainablepharma #SDGs #NicholasHall #reducewaste